GTC BIOTHERAPEUTICS
DEAD

Serial Number

78117241

Owner

Genzyme Transgenics Corporation

Attorney

Cynthia Johnson Walden

First Use Date

Feb 19, 2003

Filing Date

Mar 25, 2002

Add to watchlist:

No watchlists yet
View on USPTO

GTC BIOTHERAPEUTICS Trademark

Serial Number: 78117241 • Registration: 3356991

GTC BIOTHERAPEUTICS is a trademark filed by Genzyme Transgenics Corporation on March 25, 2002. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Genzyme Transgenics Corporation (5 trademarks)

175 Crossing Boulevard
Framingham, MA 01701

Entity Type: 03

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, S.A. (2 trademarks)

3 AVENUE DES TROPIQUES
LES ULIS 91940 , FR

Entity Type: 99

REVO BIOLOGICS, INC.

LFB S.A. 3, Avenue des Tropiques
Courtaboeuf Cedex LesUlis,91958

Entity Type: 03

GTC BIOTHERAPEUTICS, INC.

175 CROSSING BOULEVARD
FRAMINGHAM, MA 017019322

Entity Type: 03

Trademark Details

Filing Date

March 25, 2002

Registration Date

December 18, 2007

First Use Anywhere

February 19, 2003

First Use in Commerce

February 19, 2003

Published for Opposition

October 28, 2003

Cancellation Date

July 20, 2018

Goods & Services

[ Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; ] proteins [ and cloned DNA ] from [ humans, plants, ] animals [, bacteria and other micro-organisms ] for use as medical therapeutic reagents; transgenic and cloned animal products, namely, [ meat, tissue, cells or ] secretions for therapeutic and diagnostic use

[ Custom manufacture of transgenic animal products, namely, pharmaceuticals, biopharmaceuticals and proteins ]

[ Providing technical advice, research, testing and analysis in the field of pharmaceutical drug development; pharmaceutical drug development ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 20, 2018 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 18, 2016 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 10, 2014 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 10, 2014 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 7, 2014 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 18, 2014 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 9, 2014 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 5, 2014 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 18, 2007 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 15, 2007 REGV
ASSIGNED TO LIE
Nov 15, 2007 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 13, 2007 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 16, 2007 SUPC
REVIEW OF CORRESPONDENCE COMPLETE
Aug 16, 2007 CORV
SOU EXTENSION 5 GRANTED
Aug 16, 2007 EX5G
FAX RECEIVED
Aug 7, 2007 FAXX
USE AMENDMENT FILED
May 7, 2007 IUAF
SOU EXTENSION 5 FILED
May 7, 2007 EXT5
PAPER RECEIVED
May 7, 2007 MAIL
SOU EXTENSION 4 GRANTED
Oct 23, 2006 EX4G
SOU EXTENSION 4 FILED
Oct 23, 2006 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 23, 2006 EEXT
SOU EXTENSION 3 GRANTED
Apr 13, 2006 EX3G
SOU EXTENSION 3 FILED
Apr 13, 2006 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 13, 2006 EEXT
SOU EXTENSION 2 GRANTED
Oct 20, 2005 EX2G
SOU EXTENSION 2 FILED
Oct 20, 2005 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 20, 2005 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 29, 2005 TCCA
SOU EXTENSION 1 GRANTED
Feb 23, 2005 EX1G
SOU EXTENSION 1 FILED
Feb 7, 2005 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 7, 2005 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 9, 2004 NOAM
CASE FILE IN TICRS
Sep 13, 2004 CFIT
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 18, 2004 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 15, 2003 ETOF
PUBLISHED FOR OPPOSITION
Oct 28, 2003 PUBO
NOTICE OF PUBLICATION
Oct 8, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2003 CNSA
EXAMINERS AMENDMENT MAILED
Aug 29, 2003 CNEA
FINAL REFUSAL MAILED
Aug 25, 2003 CNFR
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 31, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2003 CRFA
PAPER RECEIVED
May 27, 2003 MAIL
NON-FINAL ACTION MAILED
Apr 14, 2003 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 4, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2003 CNSA
ASSIGNED TO EXAMINER
Feb 14, 2003 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2003 CRFA
PAPER RECEIVED
Jan 15, 2003 MAIL
NON-FINAL ACTION MAILED
Jul 15, 2002 CNRT
ASSIGNED TO EXAMINER
Jul 12, 2002 DOCK